Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint swelling, Lymphadenopathy, Mobility decreased, Muscle swelling
Clinical narrative: Lymph nodes under arm were swollen/ lymph nodes went down, the bursa area of shoulder; Shoulder became swollen; Shoulder extremely painful; Limited mobility; Swollen muscle in my shoulder; This is a spontaneous report from a contactable consumer (patient). A 32-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the right arm on 29Aug2021 at 07:50 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as none. The patient's concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date in 2021 (reported as 48-72 hours after receiving first dose), the patient had a swollen muscle on her shoulder. On 31Aug2021, 48 hours after the injection, the patient's lymph nodes under the arm were swollen and the patient knew it was normal. However after, swelling in the lymph nodes went down, the bursa area of her shoulder became swollen and extremely painful, resulted in limited mobility. This pain had persisted from the original date of injection. Therapeutic measures were taken as a result of event shoulder extremely painful which included treatment with naproxen sodium (ALEVE) from an unknown date to alleviate the pain at that moment. No treatment was received for the events axillary lymph nodes enlarged, joint swelling and mobility decreased. The swelling had not gone down and the pain has not subsided. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Vaccination facility type was Doctor's office/Urgent care. Vaccine was not administered at military facility. The clinical outcome of the events lymph nodes under arm were swollen/ lymph nodes went down, the bursa area of shoulder, shoulder became swollen, shoulder extremely painful and limited mobility were not recovered at the time of this report and the outcome of the event swollen muscle in her shoulder was unknown. Seriousness criteria of the event swollen muscle in her shoulder was reported as persistent/significant disability/Incapacity. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the right arm on 21Sep2021 at 09:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The clinical course was reported as follows: 48-72 hours after receiving first dose I have had a swollen muscle in my shoulder and limited mobility. I have not gone to the hospital as I am uninsured and can not afford it.  Follow-up attempts are completed. No further information is expected.  Follow-up (12Oct2021): Follow-up attempts are completed. No further information is expected.